ArticleThe Journal of biological chemistry2026
Brucella Omp25 activates the unfolded protein response to promote intracellular proliferation and inflammation.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Application of Outer Membrane Protein Omp25 in Serological Diagnosis of Brucellosis.Infectious disease reports · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brucellosis is a widespread zoonotic disease caused by Brucella, a genus of facultative intracellular bacteria that infects livestock and humans. Brucella primarily replicates within the endoplasmic reticulum (ER) of host cells, where it establishes a specialized replicative niche. This ER localization disrupts ER structure and induces ER stress. The unfolded protein response (UPR) is a critical cellular pathway that maintains ER homeostasis by restoring protein-folding capacity and regulating stress responses. However, how Brucella manipulates host UPR pathways to promote its intracellular survival and pathogenesis remains poorly understood. Here, we identify the Brucella outer membrane protein Omp25 as a key factor in promoting its intracellular survival and proliferation by activating the host UPR. Omp25 directly binds to the ER chaperone binding-immunoglobulin protein, inducing the release and activation of the UPR sensors, PKR-like ER kinase, inositol-requiring enzyme 1 alpha, and activating transcription factor 6, thereby modulating ER homeostasis to favor bacterial replication. In addition, Omp25 enhances inflammatory cytokine expression via the binding-immunoglobulin protein-inositol-requiring enzyme 1 alpha-NF-κB signaling axis. The omp25-deleted strains (Δomp25) show impaired intracellular replication and reduced UPR activation and result in attenuated induction of inflammatory genes in infected cells compared with WT strains. In vivo, mice infected with an omp25 mutant strain exhibit lower bacterial burdens and milder tissue pathology compared with mice infected with the WT strain. These findings uncover a mechanism by which Omp25 facilitates Brucella intracellular proliferation through UPR modulation and highlight Omp25 as a potential target for therapeutic interventions and next-generation attenuated vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.